Fraboc Explained: What FRA-BOC Was and Why It Matters

Introduction

Fraboc, more commonly written as FRA-BOC, was an Australian family-history risk assessment tool linked with breast and ovarian cancer. It helped health professionals check family cancer patterns and identify people who may need a closer risk assessment.

The tool is no longer available through Cancer Australia, but the term still appears in older medical resources. So, basically, if you have seen “Fraboc” somewhere and wondered what it means, this article explains its purpose, how it worked, and what is used today instead.

Quick Facts

What Is Fraboc?

Fraboc usually refers to FRA-BOC.

The name stands for Familial Risk Assessment – Breast and Ovarian Cancer.

It was an Australian online assessment tool. Cancer Australia says it was made for health professionals, including general practitioners and nurses.

Its main job was simple.
Check family cancer history.

The tool used that history to help estimate whether a woman had an average, moderately increased, or potentially high familial risk of developing breast or ovarian cancer.

Cancer Australia now states that the FRA-BOC tool is no longer available on its website and that newer breast-cancer risk tools are available.

What Did FRA-BOC Actually Do?

FRA-BOC did not find cancer.

It assessed risk patterns.

Think about a family where several close relatives developed breast cancer. Maybe one developed it very young. Another relative had ovarian cancer.

That pattern can matter.

FRA-BOC helped a health professional put family-history details into a structured risk category.

Historical Cancer Australia guidance said family history could help estimate both a woman’s chance of developing breast or ovarian cancer and the possibility of an inherited cancer-predisposing gene being present in the family.

Was Fraboc a Medical Test?

No. This is key.

FRA-BOC was not a blood test.

It was not imaging.

It was not genetic testing.

It did not diagnose breast cancer.
It did not diagnose ovarian cancer.

Basically, it was a clinical risk-assessment aid built around family history.

Someone identified as having a stronger family pattern could then be considered for a more detailed assessment, specialist referral, genetic counselling, or other care based on their situation.

What Family Information Mattered?

A proper family history needs detail.

Cancer Australia’s historical clinical material told health professionals to look at first-degree and second-degree relatives on both sides of the family.

First-degree relatives include:

• parents
• brothers and sisters
• children

Second-degree relatives include:

• grandparents
• aunts
• uncles
• nieces
• nephews

Doctors were advised to check the cancer type and the relative’s age when diagnosed.

They were also told to update the family history over time. Things change. A previously healthy relative may later receive a cancer diagnosis.

Family Patterns FRA-BOC Looked At

Some family-history patterns can raise concern more than others.

Historical Cancer Australia material listed factors such as:

• several relatives with breast or ovarian cancer
• breast cancer diagnosed at a young age
• breast and ovarian cancer occurring in the same family
• cancer affecting both breasts
• male breast cancer
• a known high-risk gene variant within a family

The mother’s family mattered.
The father’s family did too.

That’s easy to miss.

Cancer risk genes can be inherited through either side of a family.

Historical FRA-BOC Breast Cancer Categories

FRA-BOC used broad categories.

These figures come from Cancer Australia’s December 2010 clinical guidance. They are historical figures, not a current personal risk calculation.

1. At or Slightly Above Average Risk

This group covered more than 95% of the female population in the old framework.

Its estimated group risk of breast cancer up to age 75 was between 1 in 11 and 1 in 8.

The estimate was no more than 1.5 times the population average.

Examples included women with:

• no confirmed family history of breast cancer
• one first-degree relative diagnosed at age 50 or older
• one second-degree relative diagnosed at any age

Again, these were old FRA-BOC categories.

They should not be used to calculate a person’s current risk by themselves.

2. Moderately Increased Risk

The historical framework placed less than 4% of women in this group.

Group risk up to age 75 was listed between 1 in 8 and 1 in 4, or around 1.5 to three times population risk.

One example was having a first-degree relative diagnosed with breast cancer before age 50, provided stronger high-risk features were absent.

Other combinations involving two close relatives on the same side of the family could also fall here.

3. Potentially High Risk

Less than 1% of women were placed in this category under the historical system.

Its group risk estimate for breast cancer up to age 75 was between 1 in 4 and 1 in 2.

Patterns could include several relatives affected on one side of the family together with features such as:

• breast cancer before age 40
• bilateral breast cancer
• breast and ovarian cancer in one woman
• male breast cancer
• an established high-risk breast-cancer gene variant in the family

Cancer Australia’s old guidance recommended specialist family cancer assessment for women fitting potentially high-risk patterns.

How Did FRA-BOC Handle Ovarian Cancer Risk?

Ovarian cancer formed the other half of FRA-BOC.

The old Cancer Australia system again looked at cancer patterns across close blood relatives.

Its potentially high-risk category included certain families with several cases of ovarian cancer, combinations of ovarian and early breast cancer, known high-risk gene variants, or patterns suggestive of inherited cancer syndromes.

Yet one ovarian cancer case in a family did not automatically prove an inherited condition.

Context mattered.

Cancer Australia’s historical guidance also stated that ovarian cancer screening with ultrasound or CA125 had not been shown to detect early ovarian cancer effectively in the groups described there.

Fraboc and BRCA Are Not the Same Thing

This point causes confusion.

FRA-BOC assessed family history.

Genetic testing examines DNA.

Those are different jobs.

A strong family pattern might give a doctor a reason to consider genetics assessment, but FRA-BOC could never tell someone that they carried a BRCA1 or BRCA2 pathogenic variant.

A family history of breast cancer also does not automatically mean an inherited gene variant is present. Current eviQ guidance makes that distinction clear.

What Happened After a Higher-Risk Result?

FRA-BOC was useful because it could help with the next decision.

A health professional might discuss:

• more detailed risk assessment
• referral to a familial cancer service
• genetic counselling
• possible genetic testing
• breast surveillance
• risk-reduction choices

The right next step depended on the person.

It wasn’t automatic.

Cancer Australia’s historical material said family cancer clinics could assess detailed family information, discuss cancer risk, explain early detection, estimate the chance of an inherited variant, and arrange genetic testing where appropriate.

Is Fraboc Still Available?

No.

Cancer Australia clearly states that FRA-BOC is no longer available on its website.

That matters for old articles.

A page telling readers to visit Cancer Australia’s old FRA-BOC calculator is now out of date.

BreastScreen Queensland also says FRA-BOC has been replaced by iPrevent for breast-cancer risk assessment.

What Is iPrevent?

iPrevent is a current breast-cancer risk assessment and risk-management tool.

Peter MacCallum Cancer Centre says completing it takes about 30 minutes. A user can then download a personalised report to discuss with a doctor.

It asks about personal medical information and family history.

Family questions can cover breast, ovarian, pancreatic, and prostate cancer, along with the relative’s approximate age at diagnosis.

Better information can improve the assessment.

Peter Mac also says iPrevent should not be used by people who have already had invasive breast cancer or ductal carcinoma in situ, known as DCIS.

How Does iPrevent Calculate Risk?

iPrevent goes beyond the old FRA-BOC family-history categories.

Peter Mac’s information for health professionals says the system considers several breast-cancer risk factors, including personal history, reproductive factors, lifestyle information, previous breast disease, and family cancer history.

It uses validated mathematical risk models including IBIS and BOADICEA via CanRisk, depending on the information entered.

It can then create a personalised report with estimated breast-cancer risk and relevant risk-management information.

Current Risk Tools Used in Australia

FRA-BOC should now be viewed as a historical tool.

Current eviQ guidance recommends formal breast-cancer risk assessment with validated models such as:

• CanRisk
• IBIS
• iPrevent

For example, eviQ’s current moderately increased-risk protocol uses these validated tools rather than the old FRA-BOC calculator.

Current eviQ guidance also uses these models for women who may have a high breast-cancer risk and, in some situations, to help identify people who may need genetic assessment.

Can Fraboc Tell Someone If They Will Get Cancer?

No.

Risk isn’t certainty.

A person can have a higher estimated risk and never develop cancer.

Someone with no obvious family pattern can still develop breast or ovarian cancer.

That’s why risk tools estimate probability. They don’t predict an individual’s future with certainty.

Is Fraboc a Software or AI Platform?

You may see this online.

Some newer webpages use the word Fraboc for technology, workflow, business, or software-related concepts.

But those descriptions should be treated carefully.

The documented meaning supported by an Australian Government cancer agency is Familial Risk Assessment – Breast and Ovarian Cancer.

I found no comparable primary-source record establishing Fraboc as a recognized major AI platform, software product, or standard technology framework.

For factual publishing, the medical meaning has far stronger source support.

Why Is Fraboc Still Appearing in Searches?

Old resources remain online.

That’s probably a big reason.

FRA-BOC appeared in Australian cancer resources, GP information, clinical documents, and older referral material for years.

The Royal Australian College of General Practitioners, for example, discussed FRA-BOC in a 2014 article about assessing family history of breast cancer.

So someone reading an older medical record or webpage may still encounter the name today.

Should Someone Use Old FRA-BOC Risk Figures Today?

Not for a fresh personal assessment.

The old figures are useful for understanding how FRA-BOC worked.

But they come from older clinical guidance.

Current risk assessment can use newer validated models and current clinical recommendations.

eviQ now points clinicians toward tools such as CanRisk, IBIS, and iPrevent.

Anyone worried about their own family cancer history should discuss it with a qualified health professional rather than trying to self-classify with an old FRA-BOC table.

Final Thought

Fraboc has a specific documented history.

FRA-BOC meant Familial Risk Assessment – Breast and Ovarian Cancer. It helped Australian health professionals assess family-history patterns and sort patients into broad cancer-risk groups.

It was not cancer screening.

It was not genetic testing.

And it is no longer available.

Current Australian practice uses newer validated risk tools, with iPrevent, CanRisk, and IBIS among the options named in current professional guidance.

For anyone finding “Fraboc” in an old document, that’s the main point: it was a family-history risk tool, not a diagnosis.

Frequently Asked Questions

What does Fraboc mean?

Fraboc usually refers to FRA-BOC, short for Familial Risk Assessment – Breast and Ovarian Cancer.

What was FRA-BOC used for?

It helped health professionals assess breast and ovarian cancer risk based mainly on family history.

Is Fraboc still available?

No. Cancer Australia says the FRA-BOC tool is no longer available on its website.

Did Fraboc diagnose cancer?

No. It estimated familial risk. It did not diagnose breast or ovarian cancer.

Was FRA-BOC a genetic test?

No. Genetic testing is a separate process involving DNA analysis.

What replaced FRA-BOC?

BreastScreen Queensland says it has been replaced by iPrevent for breast-cancer risk assessment. Current eviQ guidance also names CanRisk and IBIS as validated risk models.

Can iPrevent be used by everyone?

No. Peter Mac says it should not be used by someone who has already had invasive breast cancer or DCIS.

Does family history always mean inherited cancer?

No. Current eviQ guidance states that having a family history of breast cancer does not necessarily mean there is an inherited genetic cause.

Spark Daily